The influence of denosumab on bone metabolism indicators in middle-aged and elderly patients with type 2 diabetes mellitus complicated with sarcopenia

PAN Fei; HU Mengting; GAN Jiaqi; ZHANG Yun; LIU Mei

doi:10.13683/j.wph.2025.07.004

World Clinical Drugs, Volume. 46, Issue 7, 651(2025)

The influence of denosumab on bone metabolism indicators in middle-aged and elderly patients with type 2 diabetes mellitus complicated with sarcopenia

PAN Fei, HU Mengting, GAN Jiaqi, ZHANG Yun, and LIU Mei

Author Affiliations

Department of General Practice, Minhang Hospital Affiliated to Fudan University, Shanghai 201199, China

show less

Abstract Get PDF(in Chinese)

Figures & Tables(0)

Tools

Get Citation

Copy Citation Text

PAN Fei, HU Mengting, GAN Jiaqi, ZHANG Yun, LIU Mei. The influence of denosumab on bone metabolism indicators in middle-aged and elderly patients with type 2 diabetes mellitus complicated with sarcopenia[J]. World Clinical Drugs, 2025, 46(7): 651

Download Citation

EndNote(RIS)BibTex Plain Text

Set citation alerts for article

Save article for my favorites

Paper Information

Category:

Received: Mar. 7, 2025

Accepted: Aug. 26, 2025

Published Online: Aug. 26, 2025

The Author Email:

DOI:10.13683/j.wph.2025.07.004

Topics